Scout Bio Closes $33 Million Series B2 Financing to Advance its Portfolio of Single Injection Gene Therapy Technology for the Treatment of Chronic Diseases in Pets

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2YYyFXb
via IFTTT